Weiguo Ye, Chief Operating Officer at GYRE THERAPEUTICS, INC. (GYRE), sold 7,500 shares at $6.08 ($46K) on 2026-05-22, disclosed to the SEC on 2026-05-27.
Open-market sale of $46k GYRE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.08 | 3,500 | $21K | 46.6% |
| 2 | $6.10 | 4,000 | $24K | 53.4% |
| Total | $6.09 avg | 7,500 | $46K | 100% |
| Filing → |
| GYRE | SELL | 2026-06-11 | $129K | — | Filing → |
| GYRE | SELL | 2026-06-08 | $219K | — | Filing → |
| GYRE | SELL | 2026-05-22 | $137K | — | Filing → |